Literature DB >> 16466303

Long-term adaptive changes induced by serotonergic antidepressant drugs.

Céline Faure1, Ouissame Mnie-Filali, Nasser Haddjeri.   

Abstract

The development of conventional antidepressants has been largely based on the hypothesis of monoaminergic dysfunctions and focuses particularly on the serotonin 5-hydroxytryptamine (5-HT) system. Hence, various classes of antidepressant treatments enhance 5-HT neurotransmission with a time course consistent with their delayed therapeutic effect. This delayed onset appears to be associated with the gradual development of specific adaptive changes of functional 5-HT receptors. However, recent theories suggest that major depressive disorders may be associated with impairments of functional plasticity and cellular flexibility. This review discusses several physiological mechanisms by which 5-HT function and hippocampal neuroplasticity are regulated. Knowledge of these long-term adaptations will increase not only our understanding of pathological processes underlying affective disorders, but could also lead to the development of new strategies to treat these devastating illnesses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466303     DOI: 10.1586/14737175.6.2.235

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  7 in total

1.  Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons.

Authors:  Daniel J Urban; Hu Zhu; Catherine A Marcinkiewcz; Michael Michaelides; Hidehiro Oshibuchi; Darren Rhea; Dipendra K Aryal; Martilias S Farrell; Emily Lowery-Gionta; Reid H J Olsen; William C Wetsel; Thomas L Kash; Yasmin L Hurd; Laurence H Tecott; Bryan L Roth
Journal:  Neuropsychopharmacology       Date:  2015-09-18       Impact factor: 7.853

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 3.  A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?

Authors:  Erika Abrial; Guillaume Lucas; Hélène Scarna; Nasser Haddjeri; Laura Lambás-Señas
Journal:  Mol Neurobiol       Date:  2011-10-05       Impact factor: 5.590

4.  Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.

Authors:  Ouissame Mnie-Filali; Céline Faure; Laura Lambás-Señas; Mostafa El Mansari; Hassina Belblidia; Elise Gondard; Adeline Etiévant; Hélène Scarna; Anne Didier; Anne Berod; Pierre Blier; Nasser Haddjeri
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

Review 5.  Phenotyping central nervous system circuitry in chronic pain using functional MRI: considerations and potential implications in the clinic.

Authors:  David Borsook; Lino Becerra
Journal:  Curr Pain Headache Rep       Date:  2007-06

6.  Any Questions? A Sober Look at MDMA.

Authors:  Luke G Petry; Monica Sharma; Aaron S Wolfgang; David A Ross; Joseph J Cooper
Journal:  Biol Psychiatry       Date:  2021-08-01       Impact factor: 12.810

7.  Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Authors:  R Rajkumar; R Mahesh
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.